Author:
Quach H,Ritchie D,Stewart A K,Neeson P,Harrison S,Smyth M J,Prince H M
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference92 articles.
1. van Rhee F, Dhodapkar M, Shaughnessy Jr JD, Anaissie E, Siegel D, Hoering A et al. First thalidomide clinical trial in multiple myeloma: a decade. Blood 2008; 112: 1035–1038.
2. Galustian C, Labarthe MC, Bartlett JB, Dalgleish AG . Thalidomide-derived immunomodulatory drugs as therapeutic agents. Exp Opin Biolog Ther 2004; 4: 1963–1970.
3. Lyer G . WHO co-ordinated short-term double-blind trial with thalidomide in the treatmetn of acute lepra reactions with male lepromatous patients. Bull World Health Organization 1971; 45: 719–732.
4. Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G . Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991; 173: 699–703.
5. D’Amato RJ, Loughnan MS, Flynn E, Folkman J . Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994; 91: 4082–4085.
Cited by
486 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献